Regulus Therapeutics
RGLS
#8339
Rank
$0.11 B
Marketcap
$1.82
Share price
6.43%
Change (1 day)
38.93%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of June 2024 : $94.46 M

According to Regulus Therapeutics's latest financial reports the company has $94.46 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$39.16 M-35.15%
2021-12-31$60.38 M94.24%
2020-12-31$31.08 M-8.89%
2019-12-31$34.12 M144.86%
2018-12-31$13.93 M-76.8%
2017-12-31$60.07 M-21.07%
2016-12-31$76.11 M-33.27%
2015-12-31$0.11 B-28.6%
2014-12-31$0.15 B40.12%
2013-12-31$0.11 B16.21%
2012-12-31$98.1 M157.18%
2011-12-31$38.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$3.77 B 3,895.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.28 B 7,611.34%๐Ÿ‡ซ๐Ÿ‡ท France
$1.90 B 1,920.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.07 B 7,391.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.62 B 2,678.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.78 M-70.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.65 B 6,943.19%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA